share_log

Surgalign Receives FDA Clearance For HOLO Portal System, The World's First AI-driven AR Guidance System For Spine Surgery

Surgalign Receives FDA Clearance For HOLO Portal System, The World's First AI-driven AR Guidance System For Spine Surgery

Surgalign 獲得 FDA 批准 HOLO Portal System,這是世界上第一個用於脊柱外科的人工智能驅動的 AR 引導系統
Benzinga Real-time News ·  2022/01/18 20:32
Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has received U.S. Food & Drug Administration (FDA) 510(k) clearance for its HOLO Portal surgical guidance system for use within lumbar spine procedures. The HOLO Portal system is the world's first artificial intelligence (AI)-driven augmented reality (AR) guidance system for spine and the first clinical application of Surgalign's HOLOTM AI digital health platform. 
Surgalign Holdings,Inc.(納斯達克代碼:SRGA)是一家專注於通過推動數位健康演進來提升護理標準的全球醫療技術公司,該公司今天宣佈,其用於腰椎手術的Holo門戶手術導航系統已獲得美國食品和藥物管理局510(K)批准。Holo門戶系統是世界上第一個由人工智慧(AI)驅動的增強現實(AR)脊柱引導系統,也是Surgalign的HOLOTM-AI數位健康平臺的首次臨床應用。 
"Receiving the initial clearance for the HOLO Portal system is a significant milestone and represents...
Surgalign首席執行官兼...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論